These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 8755785)
1. New treatments for new TB strains. Brennan PJ; MacGregor RR Pa Med; 1996 Jul; 99(7):26-7. PubMed ID: 8755785 [TBL] [Abstract][Full Text] [Related]
2. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
3. Drug-resistant mycobacterium tuberculosis; some data from Sweden, Estonia and Ethiopia. Hoffner SE Scand J Infect Dis Suppl; 1995; 98():17-8. PubMed ID: 8867172 [TBL] [Abstract][Full Text] [Related]
4. Status of drug resistance in tuberculosis after the introduction of rifampicin in India. Paramasivan CN J Indian Med Assoc; 2003 Mar; 101(3):154-6. PubMed ID: 14603961 [TBL] [Abstract][Full Text] [Related]
5. [Ways of overcoming drug resistance in patients with pulmonary tuberculosis]. Grishin MN; Svistov VV; Krivoshein IuS Probl Tuberk; 2002; (3):16-8. PubMed ID: 12066525 [TBL] [Abstract][Full Text] [Related]
6. Antimicrobial resistance in tuberculosis: an international perspective. van Helden PD; Donald PR; Victor TC; Schaaf HS; Hoal EG; Walzl G; Warren RM Expert Rev Anti Infect Ther; 2006 Oct; 4(5):759-66. PubMed ID: 17140353 [TBL] [Abstract][Full Text] [Related]
7. Risk factors for drug resistant tuberculosis in southeast Turkey. Tanrikulu AC; Hosoglu S; Ozekinci T; Abakay A; Gurkan F Trop Doct; 2008 Apr; 38(2):91-3. PubMed ID: 18453496 [TBL] [Abstract][Full Text] [Related]
8. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis]. Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568 [TBL] [Abstract][Full Text] [Related]
9. Multidrug-resistant tuberculosis (TB) resistant to fluoroquinolones and streptomycin but susceptible to second-line injection therapy has a better prognosis than extensively drug-resistant TB. Chan ED; Strand MJ; Iseman MD Clin Infect Dis; 2009 Mar; 48(5):e50-2. PubMed ID: 19191632 [TBL] [Abstract][Full Text] [Related]
13. [A-cohort study on the standard short-course chemotherapy program for drug resistant tuberculosis in the rural counties in Eastern China]. Hu Y; Jiang WL; Wang WB; Xu B Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Jun; 29(6):540-4. PubMed ID: 19040032 [TBL] [Abstract][Full Text] [Related]
14. [Chemotherapy for tuberculosis; yesterday, today, and tomorrow--basic and clinical studies]. Aoyagi T Kekkaku; 1998 Jul; 73(7):459-70. PubMed ID: 9739578 [TBL] [Abstract][Full Text] [Related]
15. Drug-resistant tuberculosis in human immunodeficiency virus infected persons in Italy. The Italian Drug-Resistant Tuberculosis Study Group. Angarano G; Carbonara S; Costa D; Gori A Int J Tuberc Lung Dis; 1998 Apr; 2(4):303-11. PubMed ID: 9559401 [TBL] [Abstract][Full Text] [Related]
16. First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran--eight years of surveillance. Shamaei M; Marjani M; Chitsaz E; Kazempour M; Esmaeili M; Farnia P; Tabarsi P; Amiri MV; Mirsaeidi M; Mansouri D; Masjedi MR; Velayati AA Int J Infect Dis; 2009 Sep; 13(5):e236-40. PubMed ID: 19285897 [TBL] [Abstract][Full Text] [Related]
17. Ofloxacin in multidrug resistant tuberculosis. Walwaikar PP; Morye VK; Gawde AS J Indian Med Assoc; 2003 Mar; 101(3):210-2. PubMed ID: 14603981 [TBL] [Abstract][Full Text] [Related]
18. Trench warfare in a battle with TB. Marshall E Science; 2008 Jul; 321(5887):362-4. PubMed ID: 18635790 [No Abstract] [Full Text] [Related]
19. Drug treatment options for multidrug-resistant tuberculosis. Patel K Conn Med; 1994 Apr; 58(4):227-30. PubMed ID: 8045123 [No Abstract] [Full Text] [Related]